1280300

GUERBET LLC — FEI 3014243475

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 28, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
683521 CFR 314.80(d)Failure to submit scientific article